Pasithea Therapeutics Corp.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

KTTA

organization

SIC: 2834

SEC Insider

$865K

79 transactions

Summary

Pasithea Therapeutics Corp. (KTTA) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $680KSales: $796.819 insiders

Date	Insider	Type	Value
2025-11-28	STEINMAN LAWRENCE	Buy	$100K
2026-06-17	Coastlands Capital LP	Buy	$53K
2025-11-28	Leahy Emer	A	$25K
2025-11-28	Dumesnil Simon	Buy	$25K
2025-11-28	Marques Tiago(Chief Executive Officer)	Buy	$25K
2025-11-28	Schneiderman Daniel H(Chief Financial Officer)	A	$20K
2025-05-12	Marques Tiago(Chief Executive Officer)	Sell	$796.8
2026-05-01	Novak Alfred J	A	$0
2026-05-01	Leahy Emer	A	$0
2026-05-01	Krishnan Kartik(Chief Medical Officer)	A	$0
2026-05-01	Schneiderman Daniel H(Chief Financial Officer)	A	$0
2026-05-01	Dumesnil Simon	A	$0
2026-05-01	STEINMAN LAWRENCE	A	$0
2026-05-01	Marques Tiago(Chief Executive Officer)	A	$0
2025-10-24	Dumesnil Simon	A	$0
2025-10-24	Leahy Emer	A	$0
2025-10-24	Marques Tiago(Chief Executive Officer)	A	$0
2025-10-24	Novak Alfred J	A	$0
2025-10-24	Schneiderman Daniel H(Chief Financial Officer)	A	$0
2025-10-24	STEINMAN LAWRENCE	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Pasithea Therapeutics Corp. — Contributions, Lobbying & Contracts | Poliscope